Metride 2 Tablet PR is a combination oral antidiabetic medication containing Glimepiride 2 mg and Metformin 500 mg, indicated for the management of type 2 diabetes mellitus. Glimepiride, a sulfonylurea class agent, functions by stimulating pancreatic beta cells to enhance insulin secretion, thereby improving glycemic control. Metformin, a biguanide, primarily acts by decreasing hepatic glucose production and improving peripheral insulin sensitivity, contributing to better glucose uptake and utilization. This dual mechanism addresses both insulin deficiency and insulin resistance, making Metride 2 effective in achieving and maintaining target blood glucose levels in patients inadequately controlled with diet and exercise alone. The prolonged-release formulation ensures sustained plasma concentration, allowing for convenient once or twice-daily dosing and improved patient compliance. Metride 2 is typically prescribed alongside lifestyle modifications such as diet and physical activity. It is contraindicated in patients with severe renal or hepatic impairment, diabetic ketoacidosis, or known hypersensitivity to its components. Common adverse effects may include gastrointestinal disturbances, hypoglycemia, and rarely, lactic acidosis. Regular monitoring of blood glucose, renal function, and periodic assessment of hepatic parameters is recommended during therapy. Metride 2 Tablet PR should be used under medical supervision with appropriate dose adjustments based on clinical response.

Dosage & How to Use